AIP
IBIO icon

Ameritas Investment Partners’s iBio IBIO Stock Holding History

Ameritas Investment Partners’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-30
Closed -$6K – 3143
2022
Q1 		$6K Hold
30
– – ﹤0.01% 2932
2021
Q4 		$8K Hold
30
– – ﹤0.01% 2962
2021
Q3 		$16K Hold
30
– – ﹤0.01% 2803
2021
Q2 		$23K Hold
30
– – ﹤0.01% 2665
2021
Q1 		$23K Hold
30
– – ﹤0.01% 2508
2020
Q4 		$16K Buy
30
+22
+275% +$17.9K ﹤0.01% 2580
2020
Q3 		$9K Hold
8
– – ﹤0.01% 2766
2020
Q2 		$9K Buy
+8
New +$5.23K ﹤0.01% 2773

Other funds holding IBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ameritas Investment Partners's IBIO Position: Q2 2022 in Review

Ameritas Investment Partners sold out of iBio (IBIO) in Q2 2022, closing a stake of 30 shares — an estimated $6K sold.

Ameritas Investment Partners first reported a position in IBIO in Q2 2020 and held it in 8 quarters. The position peaked at $23K in Q2 2021. 53 funds tracked by Wall St. Rank hold IBIO as of Q2 2022.

  • Ameritas Investment Partners reported no remaining iBio position as of Q2 2022 after selling out during the quarter.
  • Ameritas Investment Partners sold 30 iBio shares in Q2 2022, an estimated $6K.
  • Ameritas Investment Partners first reported a position in iBio in Q2 2020 and held it in 8 quarters.
  • Ameritas Investment Partners's iBio position peaked at $23K in Q2 2021.
  • 53 funds tracked by Wall St. Rank held iBio as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.